Incidence and Pathology of Primary Brain Lymphoma in Hong Kong Chinese Patients

References

• Broet CamilleriS, Davi F, Feuillard J, Seilhean D, Michiels JF, Brousset P, et al. AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum Pathol 1997; 28(3)367–74
   PubMed Web of Science ®Google Scholar
• Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ, Jr. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?. Cancer 1997; 79(12)2409–13
   PubMed Web of Science ®Google Scholar
• Auperin I, Mikolt J, Oksenhendler E, Thiebaut JB, Brunet M, Dupont B, et al. Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: expression of cellular surface proteins and Epstein-Barr viral markers. Neuropathol Appl Neurobiol 1994; 20(3)243–52
   PubMed Web of Science ®Google Scholar
• Bignon YJ, Clavelou P, Ramos F, Jouvet A, Tommasi M, Tournilhac M, et al. Detection of Epstein-Barr virus sequences in primary brain lymphoma without immunodeficiency. Neurology 1991; 41(7)1152–3
   PubMed Web of Science ®Google Scholar
• Nakhleh RE, Manivel JC, Copenhaver CM, Sung JH, Strickler JG. In situ hybridization for the detection of Epstein-Barr virus in central nervous system lymphomas. Cancer 1991; 67(2)444–8
   PubMed Web of Science ®Google Scholar
• Jellinger KA, Paulus W. Primary central nervous system lymphomas-new pathological developments. J Neurooncol 1995; 24(1)33–6
   PubMed Web of Science ®Google Scholar
• Hayakawa T, Takakura K, Abe H, Yoshimoto T, Tanaka R, Sugita K, et al. Primary central nervous system lymphoma in Japan–a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan. J Neurooncol 1994; 19(3)197–215
   PubMed Web of Science ®Google Scholar
• Liang R, Loke SL, Ho FC, Chiu E, Chan TK, Todd D. Histologic subtypes and survival of Chinese patients with non-Hodgkin's lymphomas. Cancer 1990; 66(8)1850–5
   PubMed Web of Science ®Google Scholar
• Liang RH, Woo EK, Yu YL, Todd D, Chan TK, Ho FC, et al. Central nervous system involvement in non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol 1989; 25(4)703–10
   PubMedGoogle Scholar
• Carbone A, Gaidano G, Gloghini A, Larocca LM, Capello D, Canzonieri V, et al. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 1998; 91(3)747–55
   PubMed Web of Science ®Google Scholar
• Tao Q, Srivastava G, Dickens P, Ho F. Detection of Epstein-Barr virus infected mucosal B and T lymphocytes in nasal polyps. Am J Path 1996; 149(4)1111–8
   PubMed Web of Science ®Google Scholar
• Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958–1989. Cancer 1994; 74(4)1383–97
   PubMed Web of Science ®Google Scholar
• Corry J, Smith JG, Wirth A, Quong G, Liew KH. Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys 1998; 41(3)615–20
   PubMed Web of Science ®Google Scholar
• Jensen KroghM, Johansen P, Amore F. Primary central nervous system lymphomas in immunocompetent individuals: histology, Epstein-Barr virus genome, Ki-67 proliferation index, p53 and bcl-2 gene expression. Leuk Lymphoma 1998; 30(1–2)131–42
   PubMed Web of Science ®Google Scholar
• Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16(3)859–63
   PubMed Web of Science ®Google Scholar
• Herrlinger U, Schabet M, Clemens M, Kortmann RD, Petersen D, Will BE, et al. Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta Neurol Scand 1998; 97(4)257–64
   PubMed Web of Science ®Google Scholar
• DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10(4)635–43
   PubMed Web of Science ®Google Scholar
• Pedersen C, Barton SE, Chiesi A, Skinhoj P, Katlama C, Johnson A, et al. HIV-related non-Hodgkin's lymphoma among European AIDS patients. AIDS in Europe Study Group. AIDS in Europe Study Group. Eur J Haematol 1995; 55(4)245–50
   PubMed Web of Science ®Google Scholar
• Martinez A.J. The neuropathology of organ transplantation: comparison and contrast in 500 patients. Pathol Res Pract 1998; 194(7)473–86
   PubMed Web of Science ®Google Scholar
• Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996; 10(3)248–55
   PubMed Web of Science ®Google Scholar
• Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B. Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol 1997; 10(3)13645
   Google Scholar
• Hawkins BR, Chan P, Chan YT, Cheng IK, Cheung KO, Fenn J, et al. Highly successful long-term outcome of kidney transplantation in Chinese recipients: an enhancing race effect?. Clin Transplant 1997; 11(3)178–84
   PubMed Web of Science ®Google Scholar
• Fan ST, Lo CM, Chan KL, Lo R, Saing H, Wei W, et al. Liver transplantation–perspective from Hong Kong. Hepatogastro-enterology 1996; 43(10)893–7
   PubMed Web of Science ®Google Scholar
• Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 1995; 20(5)1346–53
   PubMed Web of Science ®Google Scholar
• Schluter DeckertM, Rang A, Wiestler OD. Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system. Acta Neuropathol Berl 1998; 96(2)157–62
   PubMed Web of Science ®Google Scholar
• Nozaki M, Tada M, Mizugaki Y, Takada K, Nagashima K, Sawamura Y, et al. Expression of oncogenic molecules in primary central nervous system lymphomas in immunocompetent patients. Acta Neuropathol Berl 1998; 95(5)505–10
   PubMed Web of Science ®Google Scholar
• Larocca LM, Capello D, Rinelli A, Nori S, Antinori A, Gloghini A, et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 1998; 92(3)1011–9
   PubMed Web of Science ®Google Scholar
• Aho R, Ekfors T, Haltia M, Kalimo H. Pathogenesis of primary central nervous system lymphoma: invasion of malignant lymphoid cells into and within the brain parenchyme. Acta Neuropathol Berl 1993; 86(1)71–6
   PubMed Web of Science ®Google Scholar
• Bergmann M, Blasius S, Bankfalvi A, Mellin W. Primary non-Hodgkin lymphomas of the CNS-proliferation, oncoproteins and Epstein-Barr-virus. Gen Diagn Pathol 1996; 141(3–4)235–42
   PubMedGoogle Scholar
• Ho FC, Srivastava G, Loke SL, Fu KH, Leung BP, Liang R, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and ‘T’ cell type. Hematol Oncol 1990; 8(5)271–81
   PubMed Web of Science ®Google Scholar
• Corboy JR, Garl PJ, Kleinschmidt DeMasters BK. Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurology 1998; 50(2)335–40
   PubMed Web of Science ®Google Scholar
• Spina D, Leoncini L, Megha T, Gallorini M, Disanto A, Tosi P, et al. Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomas. J Pathol 1997; 182(2)145–50
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R, Ye BH, Lo Coco F, Chang CC, Cechova K, Zhang J, et al. BCL-6 and the molecular pathogenesis of B-cell lymphoma. Cold Spring Harbor Symposia on Quantitative Biology 1994; 59: 117–23
   PubMedGoogle Scholar
• Offit K, Lo Coco F, Louie DC, Parsa NZ, Leung D, Portlock C, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. New England Journal of Medicine 1994; 331(2)74–80
   PubMed Web of Science ®Google Scholar